Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies

Publication | Closed Access

DOI

Citations

References

2014

Year

Margriet Oosterveld, Stefan Suciu, Petra Muus, Ulrich Germing, Michel Delforge, A Belhabri, Carlo Aul, Dominik Selleslag, Augustin Ferrant, Jean‐Pierre Marie,

Annals of Hematology

Hematological MalignancyIntensive Antileukemic TreatmentMedicineAcute Myeloid LeukemiaEortc-gimema Aml-10HematologyMyeloid NeoplasiaMixed-phenotype Acute LeukemiaPrognosisOncologyRadiation OncologyCancer ResearchEmergency MedicineHealth Sciences